Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Assessment of the Molecular Diagnostic Market for HCV Genotyping NA Tests in Italy

566 views

Published on

This is the most comprehensive European market report on the emergent field of molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests performed, test volumes and used platforms and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied:Step 1: Identification of the total number of laboratories by secondary research and short telephone interviews with 732 hospitals to verify existence of internal laboratories.Step 2: 932 laboratories in Italy were classified for NAT activity and overall NA test volume.Step 3: 73 laboratories provided data on NA test volume, kits, platforms and trends. A list of 44 NA tests have been provided to the labs for structured data entry. All data has been analysed and projected at total market level. The report discusses tests and technologies that are currently available and wishes from the end user perspectives. The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), TMA, LCR, NASBA, SDA, HCA, bDNA.

Published in: Business, Economy & Finance
  • Be the first to comment

  • Be the first to like this

×